DrugCite
Search

AUGMENTIN '

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Augmentin ' Adverse Events Reported to the FDA Over Time

How are Augmentin ' adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Augmentin ', as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Augmentin ' is flagged as the suspect drug causing the adverse event.

Most Common Augmentin ' Adverse Events Reported to the FDA

What are the most common Augmentin ' adverse events reported to the FDA?

Pruritus
927 (2.12%)
Diarrhoea
815 (1.86%)
Pyrexia
784 (1.79%)
Rash
718 (1.64%)
Vomiting
590 (1.35%)
Jaundice
546 (1.25%)
Renal Failure Acute
492 (1.12%)
Dyspnoea
489 (1.12%)
Erythema
485 (1.11%)
Urticaria
465 (1.06%)
Nausea
417 (.95%)
Show More Show More
Hypotension
400 (.91%)
Alanine Aminotransferase Increased
397 (.91%)
Malaise
375 (.86%)
Anaphylactic Shock
350 (.8%)
Cholestasis
325 (.74%)
Aspartate Aminotransferase Increase...
322 (.73%)
Blood Alkaline Phosphatase Increase...
321 (.73%)
Gamma-glutamyltransferase Increased
321 (.73%)
Hepatitis Cholestatic
317 (.72%)
Rash Maculo-papular
305 (.7%)
Drug Interaction
303 (.69%)
Abdominal Pain
299 (.68%)
Toxic Skin Eruption
290 (.66%)
Hypersensitivity
276 (.63%)
Hepatitis
247 (.56%)
Drug Ineffective
239 (.55%)
Thrombocytopenia
233 (.53%)
Blood Bilirubin Increased
231 (.53%)
Asthenia
230 (.52%)
Anaphylactic Reaction
225 (.51%)
Oedema Peripheral
218 (.5%)
Face Oedema
212 (.48%)
Renal Failure
209 (.48%)
Eosinophilia
208 (.47%)
International Normalised Ratio Incr...
202 (.46%)
Rash Erythematous
202 (.46%)
Drug Hypersensitivity
198 (.45%)
General Physical Health Deteriorati...
198 (.45%)
Abdominal Pain Upper
197 (.45%)
Purpura
194 (.44%)
Angioedema
191 (.44%)
Tachycardia
191 (.44%)
Skin Exfoliation
190 (.43%)
Stevens-johnson Syndrome
190 (.43%)
Fatigue
189 (.43%)
Dehydration
188 (.43%)
Weight Decreased
186 (.42%)
Dizziness
182 (.42%)
Acute Generalised Exanthematous Pus...
177 (.4%)
Chromaturia
177 (.4%)
Toxic Epidermal Necrolysis
172 (.39%)
Hepatic Enzyme Increased
171 (.39%)
Loss Of Consciousness
171 (.39%)
Cytolytic Hepatitis
170 (.39%)
Headache
169 (.39%)
Drug Rash With Eosinophilia And Sys...
167 (.38%)
Bronchospasm
161 (.37%)
Rash Generalised
159 (.36%)
Condition Aggravated
158 (.36%)
Liver Function Test Abnormal
158 (.36%)
Anaemia
157 (.36%)
Confusional State
154 (.35%)
Pain
149 (.34%)
Dermatitis Exfoliative
144 (.33%)
Blood Creatinine Increased
143 (.33%)
Inflammation
143 (.33%)
Generalised Erythema
142 (.32%)
Agranulocytosis
141 (.32%)
Chills
139 (.32%)
Death
139 (.32%)
Leukocytosis
139 (.32%)
Transaminases Increased
138 (.31%)
Hepatic Failure
133 (.3%)
Pancytopenia
133 (.3%)
Pneumonia
131 (.3%)
Haematuria
130 (.3%)
Neutropenia
130 (.3%)
Overdose
129 (.29%)
Rash Pustular
128 (.29%)
Drug Exposure During Pregnancy
125 (.29%)
Jaundice Cholestatic
121 (.28%)
Oedema
121 (.28%)
Skin Lesion
121 (.28%)
Cardiac Arrest
117 (.27%)
Sepsis
116 (.26%)
Haemoglobin Decreased
115 (.26%)
Rash Pruritic
115 (.26%)
Convulsion
113 (.26%)
Product Quality Issue
113 (.26%)
Liver Disorder
112 (.26%)
Anorexia
110 (.25%)
Clostridium Difficile Colitis
109 (.25%)
Leukopenia
109 (.25%)
Blister
105 (.24%)
C-reactive Protein Increased
105 (.24%)
Erythema Multiforme
101 (.23%)
Arthralgia
98 (.22%)
Dysphagia
97 (.22%)
Lung Disorder
97 (.22%)
Rash Macular
97 (.22%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Augmentin ', as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Augmentin ' is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Augmentin '

What are the most common Augmentin ' adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Augmentin ', as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Augmentin ' is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Augmentin ' According to Those Reporting Adverse Events

Why are people taking Augmentin ', according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
1306
Sinusitis
537
Product Used For Unknown Indication
515
Bronchitis
452
Infection
398
Pneumonia
382
Show More Show More
Urinary Tract Infection
363
Prophylaxis
322
Ill-defined Disorder
205
Upper Respiratory Tract Infection
202
Ear Infection
191
Lung Disorder
186
Pyrexia
179
Lower Respiratory Tract Infection
161
Erysipelas
150
Antibiotic Prophylaxis
143
Cellulitis
140
Tonsillitis
128
Acute Sinusitis
125
Cough
121
Respiratory Tract Infection
117
Helicobacter Infection
114
Pharyngitis
113
Infection Prophylaxis
112
Tooth Abscess
103
Bronchopneumonia
96
Lung Infection
95
Otitis Media
89
Bacterial Infection
77
Skin Infection
67
Toothache
56
Acute Tonsillitis
55
Antibiotic Therapy
55
Oropharyngeal Pain
53
Tooth Infection
51
Respiratory Disorder
47
Sepsis
45
Abscess
44
Nasopharyngitis
43
Influenza
42
Wound Infection
40
Bronchopneumopathy
39
Chronic Sinusitis
38
Pharyngolaryngeal Pain
36
Pneumonia Aspiration
34
Cystitis
33
Otitis Media Acute
32
Pyelonephritis
30
Pneumonia Bacterial
29
Diverticulitis
29
Chronic Obstructive Pulmonary Disea...
27

Augmentin ' Case Reports

What Augmentin ' safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Augmentin '. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Augmentin '.